New Gene Therapy Could Help Quell Alcoholic Cravings

Join Our Community of Science Lovers!

One prevailing view of addiction holds that alcohol and other drugs alter the way dopamine works in the brain. These substances increase the brain's production of dopamine, a neurotransmitter associated with feelings of pleasure and reward. But at the same time, they deplete the number of available D-2 dopamine receptors, which are necessary to appreciate the buzz excess dopamine can bring. As a result, addicts try to increase their intake to compensate for a blunted pleasure response¿all the time.

A new study from Panayotis Thanos and colleagues at Brookhaven National Laboratory has found that restoring depleted D-2 receptors in the brains of 'alcoholic' lab rats, even temporarily, can quell the animals' cravings. "This is a preliminary study, but when you see a rat that chooses to drink 80 to 90 percent of its daily fluid as alcohol, and then three days later it's down to 20 percent, that's a dramatic drop in alcohol intake¿a very clear change in behavior," Thanos says. "This gives us great hope that we can refine this treatment for future clinical use."

The researchers introduced the gene for the D2 receptor directly into the pleasure centers of the rats' brains using a modified virus. Brain scans revealed that the animals developed higher levels of D2 receptors within three to four days, and then returned to normal eight days after the injection. Among rats trained to take alcohol instead of water, the gene therapy reduced their preference by 43 percent. These animals also drank 64 percent less alcohol than rats that received placebo injections. Even rats with low preference for booze drank significantly less after treatment.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The effects of the gene therapy wore off in a week, but fresh injections put the rats back on the wagon. "This is the first evidence that overproduction of D2 receptors reduces alcohol intake," Thanos says, "and suggests that high levels of D2 may be protective against alcohol abuse in humans."

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe